Biochemistry Referrals - NHS Greater Glasgow & Clyde

The procurement process for Biochemistry Referrals has been concluded by the Gateshead Health NHS Foundation Trust and awarded to NHS Greater Glasgow & Clyde. This contract falls under the industry category of services provided by medical laboratories and is guided by the Health Care Services (Provider Selection Regime) Regulations 2023, applying a direct award process. Located in the United Kingdom, specifically at Queen Elizabeth Hospital in Gateshead, the contract commenced on 3rd June 2025 and will run until 31st March 2028, with a total value of £6000.

This tender process bypassed the typical procurement act provisions, allowing for a more streamlined award without prior publication of a call for competition. This tender presents opportunities for businesses, particularly those within the medical laboratory services sector, to align with NHS standards and potentially expand their services across regions. The contract's emphasis on compatible analytical methodologies and UKAS accreditation suggests that experienced firms with rigorous quality controls and national recognition would particularly benefit.

Small to medium enterprises positioned in the health services domain may find such contracts a stepping stone towards larger healthcare service collaborations, offering a pathway to strengthen their capabilities and reputation within the public health sector.